President-elect Biden will likely move quickly to undo a slew of Trump-era health care policies.
Health reporters from Politico and The Washington Post joined Urban's Linda Blumberg for a fresh look at the candidates' plans for health reform— and the very real challenges they'd face.
NYT's Katie Thomas shares how she finds and vets stories of real people stung by ever-rising drug prices, and expert panelists provide key context for rounding out coverage.
Iowa's version of the Medicaid expansion sought to lure more people into receiving preventative care by offering to waive monthly premiums. The incentive program has largely failed, and here's why.
Why not allow Medicare to negotiate lower prescription drug prices? Economists such as Neeraj Sood worry such a move would hamper crucial innovations over time. But not everyone agrees.
A sizable percentage of California farmworkers are still struggling to get access to health services for themselves and their families.
Washington state Medicaid officials are changing the rule for coverage of vitamins that contain folic acid — a change that may reduce the risk of birth defects like those seen in an ongoing cluster in Central Washington.
This article, originally published by the Los Angeles Times, was reported as a project for the California Endowment Health Journalism Fellowships at USC's Annenberg School for Communication and Journalism....
In some states, reimbursements are so low that doctors say they lose money when they see Medicaid patients. And that can make it harder for patients to see their doctor — a recent study found that higher rates improve access to care.
New data show that tax credits have dramatically lowered premiums for those on Obamacare plans. But for employees stuck with high-deductible plans, big out-of-pocket costs can drain bank accounts and incentivize going without care.
